Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,711,515
+$1,960,200 QoQ
Shares Held
649,873
+5.8% QoQ
Ownership
0.630%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MPM BIOIMPACT LLC holds $1,223,258,298 across 39 Biotechnology names. VRDN ranks #34 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DBVT |
DBV Technologies S.A.
|
5,213,361 | $108,907,111 | |
| 2 | CGEM |
Cullinan Therapeutics, Inc.
|
7,648,268 | $108,681,888 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
4,835,872 | $86,513,750 | |
| 4 | ALMS |
Alumis Inc.
|
2,386,529 | $52,575,233 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,660,696 | $52,311,924 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
506,776 | $49,283,966 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,306,261 | $44,190,809 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
985,700 | $39,733,567 |
All Filings in VRDN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,711,515 | 649,873 | Shares | Sole | 2026-05-15 | |
| 2024-03-31 | $10,751,315 | 614,010 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,178,000 | 100,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,916,654 | 255,323 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,074,134 | 255,323 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||